The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Open accessAbstract
Notwithstanding the potential public health impact of the polycystic ovary syndrome (PCOS), estimates regarding its prevalence are limited and unclear. Between July 1998 and October 1999, 400 unselected consecutive premenopausal women (18-45 yr of age) seeking a preemployment physical at the University of Alabama at Birmingham were studied (223 Black, 166 White, and 11 of other races). Evaluation included a history and physical examination, a modified Ferriman-Gallwey hirsutism score, and serum screening for hyperandrogenemia, hyperprolactinemia, and 21-hydroxylase-deficient nonclassical adrenal hyperplasia. PCOS was diagnosed by the presence of the following: 1) oligoovulation, 2) hyperandrogenemia and/or hirsutism (modified Ferriman-Gallwey score > or = 6), and 3) the exclusion of related disorders. Confirmed PCOS was established in those individuals whose evaluation was complete and indicative of PCOS, and possible PCOS was established when the hormonal evaluation was not complete or was unavailable, but the clinical phenotype was otherwise suggestive of the disorder. The individual probability of PCOS in women with possible PCOS was assigned a weight based on the findings in similar subjects whose evaluation was complete, and the total number of PCOS cases arising from these individuals was calculated (i.e. individual probability of PCOS x total number of subjects in the group). The cumulative prevalence of PCOS in our population was 6.6% (26.5 of 400), including 15 subjects among the 347 women completing their evaluation and a calculated prevalence of 11.5 subjects among the remainder. The prevalence rates of PCOS for Black and White women were 8.0 and 4.8%, respectively, not significantly different. These data from a large representative unselected population support the concept that PCOS is the most common endocrine abnormality of reproductive-aged women in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Legro, R. S. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0004 · Cited by 466
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
Solomon, C. G. (2001) · JAMA · doi:10.1001/jama.286.19.2421 · Cited by 362 · cited 2×
“4% rate of physician-diagnosed hirsutism reported by the participants of the Nurses’ Health Study II (19).”
Azziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244
Self-citation
Cited by
Items 101–193 of 193
Puurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment
An, Y., Sun, Z., Zhang, Y., Liu, B., Guan, Y., & Lu, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12294 · Cited by 105
Avery, J. C., & Braunack-Mayer, A. J. (2007) · BMC Women's Health · doi:10.1186/1472-6874-7-9 · Cited by 100
“However, another 2000 study concerning women in the USA aged 18 to 45 years, white and black with PCOS (overall prevalence of 6.6%, n = 400) had a prevalence of 66% with menstrual disorders only, 19% with hirsutism only, and 14.7% experiencing both [ 8 ].”
BackgroundInfluentialIntersection of Polycystic Ovary Syndrome and the Gut Microbiome
Rizk, M. G., & Thackray, V. G. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa177 · Cited by 104
Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women
Liou, T.-H., Yang, J.-H., Hsieh, C.-H., Lee, C.-Y., Hsu, C.-S., & Hsu, M.-I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.003 · Cited by 100
Tefagh, G., Payab, M., Qorbani, M., Sharifi, F., Sharifi, Y., Ebrahimnegad Shirvani, M. S., Pourghazi, F., Atlasi, R., Shadman, Z., Rezaei, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09082-3 · Cited by 102
Sohaei, S., Amani, R., Tarrahi, M. J., & Ghasemi-Tehrani, H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102201 · Cited by 100
Barrera, F. J., Brown, E. D. L., Rojo, A., Obeso, J., Plata, H., Lincango, E. P., Terry, N., Rodríguez-Gutiérrez, R., Hall, J. E., & Shekhar, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106625 · Cited by 91
Pizzo, A., Laganà, A. S., & Barbaro, L. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2013.860120 · Cited by 90
Predicting polycystic ovary syndrome with machine learning algorithms from electronic health records
Zad, Z., Jiang, V. S., Wolf, A. T., Wang, T., Cheng, J. J., Paschalidis, I. C., & Mahalingaiah, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1298628 · Cited by 97
Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management
Farshchi, H., Rane, A., Love, A., & Kennedy, R. L. (2007) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610701667338 · Cited by 87
Kahal, H., Kyrou, I., Uthman, O. A., Brown, A., Johnson, S., Wall, P. D. H., Metcalfe, A., Parr, D. G., Tahrani, A. A., & Randeva, H. S. (2020) · Sleep and Breathing · doi:10.1007/s11325-019-01835-1 · Cited by 87
Merz, C. N. B., Shaw, L. J., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2016) · Journal of Women's Health · doi:10.1089/jwh.2015.5441 · Cited by 87
Self-citationLow levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?
Muscogiuri, G., Policola, C., Prioletta, A., Sorice, G., Mezza, T., Lassandro, A., Della Casa, S., Pontecorvi, A., & Giaccari, A. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2011.12.010 · Cited by 86
Children's Hospital Association Consensus Statements for Comorbidities of Childhood Obesity
Estrada, E., Eneli, I., Hampl, S., Mietus-Snyder, M., Mirza, N., Rhodes, E., Sweeney, B., Tinajero-Deck, L., Woolford, S. J., & Pont, S. J. (2014) · Childhood Obesity · doi:10.1089/chi.2013.0120 · Cited by 85
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85
Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
Hahn, S., Kuehnel, W., Tan, S., Kramer, K., Schmidt, M., Roesler, S., Kimmig, R., Mann, K., & Janssen, O. E. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.031 · Cited by 82
The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.
(2015) · PubMed Central · Cited by 81
Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population
Sirmans, S. M., Parish, R. C., Blake, S., & Wang, X. (2014) · Journal of Investigative Medicine · doi:10.1097/01.jim.0000446834.90599.5d · Cited by 79
Graff, S. K., Mário, F. M., Alves, B. C., & Spritzer, P. M. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.06.005 · Cited by 79
Jamil, A. S., Alalaf, S. K., Al-Tawil, N. G., & Al-Shawaf, T. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3889-5 · Cited by 73
The Polycystic Ovary Syndrome and recent human evolution
Corbett, S., & Morin-Papunen, L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.001 · Cited by 68
Ezeh, U., Pall, M., Mathur, R., & Azziz, R. (2014) · Human Reproduction · doi:10.1093/humrep/deu096 · Cited by 71
Self-citationAroda, V. R., Ciaraldi, T. P., Burke, P., Mudaliar, S., Clopton, P., Phillips, S., Chang, R. J., & Henry, R. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1133 · Cited by 71
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00758.x · Cited by 70
Barth, J. H., Field, H. P., Yasmin, E., & Balen, A. H. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0741 · Cited by 69
Li, X.-J., Yu, Y.-X., Liu, C.-Q., Zhang, W., Zhang, H.-J., Yan, B., Wang, L.-Y., Yang, S.-Y., & Zhang, S.-H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03917.x · Cited by 67
Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome
Nandalike, K., Agarwal, C., Strauss, T., Coupey, S. M., Isasi, C. R., Sin, S., & Arens, R. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.07.002 · Cited by 68
Approach to patients with pseudo-Cushing’s states
Scaroni, C., Albiger, N. M., Palmieri, S., Iacuaniello, D., Graziadio, C., Damiani, L., Zilio, M., Stigliano, A., Colao, A., Pivonello, R., et al. (2020) · Endocrine Connections · doi:10.1530/ec-19-0435 · Cited by 68
A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries
Niafar, M., Pourafkari, L., Porhomayon, J., & Nader, N. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3976-7 · Cited by 66
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
Ozkaya, M., Cakal, E., Ustun, Y., & Engin-Ustun, Y. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.10.058 · Cited by 67
Zhou, Y., Wang, X., Jiang, Y., Ma, H., Chen, L., Lai, C., Peng, C., He, C., & Sun, C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1347779 · Cited by 64
Flannery, C. A., Rackow, B., Cong, X., Duran, E., Selen, D. J., & Burgert, T. S. (2013) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00902.x · Cited by 62
Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63
Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS)
Scaruffi, E., Franzoi, I. G., Civilotti, C., Guglielmucci, F., La Marca, L., Tomelini, M., Veglia, F., & Granieri, A. (2019) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/0167482x.2018.1530210 · Cited by 62
Karabulut, A., Yaylali, G. F., Demirlenk, S., Sevket, O., & Acun, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.589929 · Cited by 61
Reyes-Muñoz, E., Castellanos-Barroso, G., Ramírez-Eugenio, B. Y., Ortega-González, C., Parra, A., Castillo-Mora, A., & De la Jara-Díaz, J. F. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.023 · Cited by 61
Forslund, M., Landin‐Wilhelmsen, K., Schmidt, J., Brännström, M., Trimpou, P., & Dahlgren, E. (2019) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13489 · Cited by 60
Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis
Zeng, L., & Yang, K. (2018) · Endocrine · doi:10.1007/s12020-017-1442-y · Cited by 59
Johnson, S., Weddell, S., Godbert, S., Freundl, G., Roos, J., & Gnoth, C. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-1087 · Cited by 61
Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008) · Human Reproduction · doi:10.1093/humrep/den273 · Cited by 58
Amiri, M., Ramezani Tehrani, F., Nahidi, F., Bidhendi Yarandi, R., Behboudi‐Gandevani, S., & Azizi, F. (2017) · Clinical Endocrinology · doi:10.1111/cen.13389 · Cited by 57
Tee, M. K., Dong, Q., & Miller, W. L. (2008) · Endocrinology · doi:10.1210/en.2007-1527 · Cited by 55
Littlejohn, E. E., Weiss, R. E., Deplewski, D., Edidin, D. V., & Rosenfield, R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.1.41 · Cited by 55
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55
Butt, M. S., Saleem, J., Zakar, R., Aiman, S., Khan, M. Z., & Fischer, F. (2023) · BMC Public Health · doi:10.1186/s12889-023-15730-8 · Cited by 52
Tiwari, N., Pasrija, S., & Jain, S. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.12.021 · Cited by 50
Feng, L., Lin, X.-F., Wan, Z.-H., Hu, D., & Du, Y.-K. (2015) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1041906 · Cited by 50
Patel, R., & Shah, G. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1279597 · Cited by 47
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J., & Pfeifer, M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0857 · Cited by 47
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Toscani, M. K., Mario, F. M., Radavelli-Bagatini, S., & Spritzer, P. M. (2011) · Nutrition Research · doi:10.1016/j.nutres.2011.01.009 · Cited by 47
A life course perspective on polycystic ovary syndrome
Sanchez, N. (2014) · International Journal of Women's Health · doi:10.2147/ijwh.s55748 · Cited by 43
A snapshot of the lives of women with polycystic ovary syndrome: A photovoice investigation
Williams, S., Sheffield, D., & Knibb, R. C. (2016) · Journal of Health Psychology · doi:10.1177/1359105314547941 · Cited by 44
Amiri, M., Kabir, A., Nahidi, F., Shekofteh, M., & Ramezani Tehrani, F. (2018) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2018.1435779 · Cited by 40
Jabbour, R., Ott, J., Eppel, W., & Frigo, P. (2020) · PLOS ONE · doi:10.1371/journal.pone.0232299 · Cited by 43
Fertility concerns and related information needs and preferences of women with PCOS
Holton, S., Hammarberg, K., & Johnson, L. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy019 · Cited by 43
Song, D. K., Lee, H., Oh, J.-Y., Hong, Y. S., & Sung, Y.-A. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.4.302 · Cited by 43
Varanasi, L. C., Subasinghe, A., Jayasinghe, Y. L., Callegari, E. T., Garland, S. M., Gorelik, A., & Wark, J. D. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12730 · Cited by 42
Martin, M. L., Halling, K., Eek, D., Krohe, M., & Paty, J. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0736-3 · Cited by 40
Apnea–hypopnea index in nonobese women with polycystic ovary syndrome
Yang, H., Kang, J., Su, H., Tzeng, C., Liu, W., & Huang, S. (2009) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.02.004 · Cited by 40
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Clinical Variability in Approaches to Polycystic Ovary Syndrome
Bonny, A. E., Appelbaum, H., Connor, E. L., Cromer, B., DiVasta, A., Gomez-Lobo, V., Harel, Z., Huppert, J., & Sucato, G. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.03.004 · Cited by 38
Associations between vitamin D levels and polycystic ovary syndrome phenotypes
Davis, E. M., Peck, J. D., Hansen, K. R., Neas, B. R., & Craig, L. B. (2019) · Minerva Endocrinologica · doi:10.23736/s0391-1977.18.02824-9 · Cited by 39
Chen, T., Yu, Y., Jia, F., Luan, P., & Liu, X. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.960965 · Cited by 37
Marinkovic-Radosevic, J., Cigrovski Berkovic, M., Kruezi, E., Bilic-Curcic, I., & Mrzljak, A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.932 · Cited by 35
Intact Primary Mitochondrial Function in Myotubes Established from Women with PCOS
Eriksen, M. B., Minet, A. D., Glintborg, D., & Gaster, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0278 · Cited by 35
Tsai, Y.-H., Wang, T.-W., Wei, H.-J., Hsu, C.-Y., Ho, H.-J., Chen, W.-H., Young, R., Liaw, C.-M., & Chao, J. C.-J. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004369 · Cited by 34
Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes
Hong, S.-H., Hong, Y. S., Jeong, K., Chung, H., Lee, H., & Sung, Y.-A. (2020) · Scientific Reports · doi:10.1038/s41598-020-66633-2 · Cited by 32
Skeletal muscle mitochondrial function in polycystic ovarian syndrome
Rabøl, R., Svendsen, P. F., Skovbro, M., Boushel, R., Schjerling, P., Nilas, L., Madsbad, S., & Dela, F. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0419 · Cited by 33
Wang, X., Wang, H., Liu, W., Zhang, Z., Zhang, Y., Zhang, W., Chen, Z., Xia, G., & Wang, C. (2018) · Clinical Science · doi:10.1042/cs20171394 · Cited by 30
Sanchez, N., & Jones, H. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5417 · Cited by 30
Ito, K., Miki, Y., Suzuki, T., McNamara, K. M., & Sasano, H. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0470 · Cited by 29
Nutrient Patterns and Risk of Polycystic Ovary Syndrome.
(2019) · Europe PMC (PubMed Central) · Cited by 27
Al-Zubeidi, H., & Klein, K. O. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0283 · Cited by 24
Deveer, M., Deveer, R., Basaran, O., Turkcu, U. O., Akbaba, E., Cullu, N., Turhan, N., Kucuk, M., & Kasap, B. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2375w · Cited by 22
Bahadur, A., Arora, H., Ravi, A. K., Naithani, M., Bahurupi, Y., Chaturvedi, J., Ajmani, M., & Mundhra, R. (2021) · Cureus · doi:10.7759/cureus.15510 · Cited by 22
Modeling Endocrine Control of the Pituitary–Ovarian Axis: Androgenic Influence and Chaotic Dynamics
Hendrix, A. O., Hughes, C. L., & Selgrade, J. F. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-013-9913-7 · Cited by 19
A meta-analysis of the relationship between polycystic ovary syndrome and sleep disturbances risk
Wang, C., Huang, T., Song, W., Zhu, J., Liu, Y., Chen, X., Sun, X., Wu, Q., Chen, H., Liao, H., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.957112 · Cited by 19
Dynamics and bifurcation of a model for hormonal control of the menstrual cycle with inhibin delay
Margolskee, A., & Selgrade, J. F. (2011) · Mathematical Biosciences · doi:10.1016/j.mbs.2011.09.001 · Cited by 18
Nahuis, M. J., Oude Lohuis, E. J., Bayram, N., Hompes, P. G. A., Oosterhuis, G. J. E., van der Veen, F., Mol, B. W. J., & van Wely, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.09.004 · Cited by 18
Interventions for the metabolic dysfunction in polycystic ovary syndrome
Bozdag, G., & Yildiz, B. O. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.008 · Cited by 18
Self-citationPolycystic ovaries: Review of medical information on the internet for patients
Mallappa Saroja, C. S., & Hanji Chandrashekar, S. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1378-4 · Cited by 16
Pancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metformin
Messer, C., Boston, R., Leroith, D., Geer, E., Miller, J. D., Messer, M., & Futterweit, W. (2012) · Endocrine Practice · doi:10.4158/ep11375.or · Cited by 16
LeBlanc, E. S., Brooks, N., Davies, M., & Chatterjee, R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae655 · Cited by 11
Peven, K., Wickham, A. P., Wilks, O., Kaplan, Y. C., Marhol, A., Ahmed, S., Bamford, R., Cunningham, A. C., Prentice, C., Meczner, A., et al. (2023) · JMIR mHealth and uHealth · doi:10.2196/46718 · Cited by 9
Pandit, D. V. K., Setiya, D. M., Yadav, D. S., & Jehan, D. M. (2016) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-1508105864 · Cited by 6
Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.
(2012) · PubMed · doi:10.3275/7872 · Cited by 5
Polycystic Ovary Syndrome (PCOS): From Diagnosis to Treatment
Rani, R., Priyanka, P., Yadav, R., Bajal, N., Mandal, B. S., & Kumar, A. (2024) · International Journal of Environment, Agriculture and Biotechnology · doi:10.22161/ijeab.94.5 · Cited by 4
The Epidemiology of Polycystic Ovary Syndrome
Suturina, L. (2022) · Polycystic Ovary Syndrome · doi:10.1017/9781108989831.003 · Cited by 4
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Metadata
- Authors
- Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-06
- Volume
- 89
- Issue
- 6
- Pages
- 2745-2749
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2096887626
- Cited by
- 2,712
- References
- 4
- FWCI
- 61.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.